Adverse events during antipsychotic clinical trials of elderly patients with dementia

被引：0
|
作者：
Kryzhanovskaya, L [1 ]
Cavazzoni, P [1 ]
Young, C [1 ]
Polzer, J [1 ]
Jansen, J [1 ]
Baker, R [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
SCHIZOPHRENIA BULLETIN | 2005年 / 31卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：565 / 566
页数：2
相关论文
共 50 条
  • [31] Clinical trials in elderly patients
    Jackson, S. H. D.
    [J]. Appropriate Dose Selection - How to Optimize Clinical Drug Development, 2007, 59 : 101 - 109
  • [32] On Analysis of Low Incidence Adverse Events in Clinical Trials
    Liu, G. Frank
    [J]. TOPICS IN APPLIED STATISTICS, 2013, 55 : 273 - 282
  • [33] Serious adverse events in clinical trials with TAVR and SAVR
    Barth, U.
    [J]. HERZ, 2019, 44 (06) : 526 - 533
  • [34] Improving attribution of adverse events in oncology clinical trials
    George, Goldy C.
    Barata, Pedro C.
    Campbell, Alicyn
    Chen, Alice
    Cortes, Jorge E.
    Hyman, David M.
    Jones, Lee
    Karagiannis, Thomas
    Klaar, Sigrid
    Le-Rademacher, Jennifer G.
    LoRusso, Patricia
    Mandrekar, Sumithra J.
    Merino, Diana M.
    Minasian, Lori M.
    Mitchell, Sandra A.
    Montez, Sandra
    O'Connor, Daniel J.
    Pettit, Syril
    Silk, Elaine
    Sloan, Jeff A.
    Stewart, Mark
    Takimoto, Chris H.
    Wong, Gilbert Y.
    Yap, Timothy A.
    Cleeland, Charles S.
    Hong, David S.
    [J]. CANCER TREATMENT REVIEWS, 2019, 76 : 33 - 40
  • [35] Adverse events in clinical trials: is a new approach needed?
    Barrios, Vivencio
    Escobar, Carlos
    Prieto, Luis
    Herranz, Inmaculada
    [J]. LANCET, 2008, 372 (9638): : 535 - 536
  • [36] Reporting of Psychiatric Adverse Events in Randomised Clinical Trials
    Willemen, M. J. C.
    Mantel-Teeuwisse, A. K.
    Straus, S. M. J. M.
    Egberts, A. C. G.
    Leufkens, H. G. M.
    [J]. DRUG SAFETY, 2010, 33 (10) : 936 - 936
  • [37] Adverse events with Z-drugs in patients with dementia
    [J]. Reactions Weekly, 2020, 1833 (1) : 2 - 2
  • [38] Measuring frailty in clinical trials for dementia and MCI and investigating its relationship with serious adverse events and trial attrition
    Wightman, Heather
    Hanlon, Peter
    McAllister, David
    Quinn, Terry
    Mair, Frances
    Lewsey, Jim
    [J]. AUSTRALIAN JOURNAL OF PRIMARY HEALTH, 2022, 28 (04) : LXV - LXV
  • [39] Antipsychotic serious adverse events in context
    Suzuki, Takefumi
    [J]. LANCET PSYCHIATRY, 2019, 6 (09): : 717 - 718
  • [40] Risperidone and cerebrovascular adverse in elderly patients with dementia - Reply
    Jentoft, A. J. Cruz
    [J]. REVISTA CLINICA ESPANOLA, 2006, 206 (08): : 412 - 413
12345